Combination therapy with long-acting -agonists plus inhaled corticosteroids is no more effective than LABA monotherapy for mortality outcomes and severe exacerbations in moderate to very severe COPD and is associated with serious adverse effects
Keyword(s):
Keyword(s):
2004 ◽
Vol 10
(28)
◽
pp. 3547-3560
◽
2018 ◽
Vol 24
(5)
◽
pp. 478-486
2014 ◽
Vol 133
(2)
◽
pp. AB177
Keyword(s):
Keyword(s):
2006 ◽
Vol 12
(25)
◽
pp. 3261-3279
◽
2010 ◽
Vol 31
(03)
◽
pp. 321-333
◽
Keyword(s):